Non small cell lung cancer overview: Difference between revisions
No edit summary |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
'''Non-small cell lung | '''Non-small cell lung cancer''' ('''NSCLC''') is any type of epithelial [[lung cancer]] other than [[small-cell lung cancer]] (SCLC). Non-small cell lung cancer may be classified according to the WHO histological classification system into 3 main types: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Other less common subtypes, include: adenosquamous lung carcinoma, pulmonary sarcomatoid carcinoma, carcinoid tumors of lung, and carcinomas of the lung of salivary gland type.<ref name="NSCLC"> Non-Small Cell Lung Cancer Treatment –for health professionals. National Cancer Institute – Physician Data Query PDQ. http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#link/_361_toc Accessed on February 3, 2016.</ref> NSCLC arises from the epithelial cells of the lung of the central bronchi to terminal alveoli. [[Genes]] involved in the pathogenesis of non-small cell lung cancer include [[EGFR]], [[KRAS]], [[HER2]], [[BRAF]], and ALK. The main cause of non-small cell lung cancer is DNA damage. Non-small cell lung cancer is the most common cancer among the adult population in the United States.<ref name="NSCLS">SEER Stat Fact Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.html Accessed on February 3 2016</ref><ref name="NsdS"> Non-small cell lung cancer. https://en.wikipedia.org/wiki/Non-small-cell_lung_carcinoma Accessed on February 3 2016 </ref name="FACTS">American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society, 2016. Available online. Accessed February 3</ref> These tumors account for about 85% of all lung cancers. The incidence rate of non-small cell lung cancer is approximately 42.6 per 100 000 individuals in the United States. NSCLC tumors are relatively insensitive to [[chemotherapy]], compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively ([[Neoadjuvant therapy|neoadjuvant chemotherapy]]) and post-operatively ([[Adjuvant therapy|adjuvant chemotherapy]]). | ||
==Historical Perspective== | ==Historical Perspective== | ||
Non small cell lung cancer was first described by Thomas Venner of London in 1620. | Non-small cell lung cancer was first described by Thomas Venner of London in 1620.<ref name="pmid11606795">{{cite journal |author=Witschi H |title=A short history of lung cancer |journal=[[Toxicological Sciences : an Official Journal of the Society of Toxicology]] |volume=64 |issue=1 |pages=4–6 |year=2001 |month=November |pmid=11606795 |doi= |url=http://toxsci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11606795 |accessdate=2011-12-09}}</ref> | ||
==Classification== | ==Classification== | ||
| Line 16: | Line 16: | ||
==Pathophysiology== | ==Pathophysiology== | ||
Non-small cell lung cancer arises from the [[epithelial]] cells of the lung of the central [[bronchi]] to terminal [[alveoli]], which are normally involved in the protection of the airways. Non-small cell lung cancer is an invasive and rapidly growing cancer which may metastasize to different organs of the body. [[Genes]] involved in the pathogenesis of non-small cell lung cancer include [[EGFR]], [[KRAS]], [[HER2]], [[BRAF]], and ALK. On gross pathology, findings will depend on the histological type. On microscopic histopathological analysis non-small cell lung cancer demonstrate large cells with abundant cytoplasm and no stippled chromatin. | |||
==Causes== | ==Causes== | ||
The primary cause of non-small cell lung cancer is DNA damage and genetic mutations in [[EGFR]], [[KRAS]], [[ALK]], [[HER2]], and [[BRAF]] genes.<ref name="NsdS"> Non-small cell lung cancer. https://en.wikipedia.org/wiki/Non-small-cell_lung_carcinoma Accessed on February 3 2016</ref> | |||
==Differentiating Non Small Cell Carcinoma of the Lung from other Diseases== | ==Differentiating Non Small Cell Carcinoma of the Lung from other Diseases== | ||
Non-small cell lung cancer must be differentiated from other diseases that cause chronic cough, weight loss, hemoptysis, and dyspnea among adults such as tuberculosis, fungal infections, and secondary metastases. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Non-small cell lung cancer is the most common cancer among the adult population in the United States.<ref name="NSCLS">SEER Stat Fact Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.html Accessed on February 3 2016</ref><ref name="NsdS"> Non-small cell lung cancer. https://en.wikipedia.org/wiki/Non-small-cell_lung_carcinoma Accessed on February 3 2016</ref><ref name="FACTS">American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society, 2016. Available online. Accessed February 3</ref> These tumors account for about 85% of all lung cancers. The incidence rate of non-small cell lung cancer is approximately 42.6 per 100 000 individuals in the United States. The incidence of non-small cell lung cancer increases with age; the median age at diagnosis is between 5 to 7 years. Males are more commonly affected with non-small cell lung cancer than females. The male to female ratio is approximately 1.5 to 1.<ref name="NSCLS"> SEER Stat Fact Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.html Accessed on February 3 2016</ref> | |||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of non small cell lung are smoking, family history of [[lung cancer]], high levels of air pollution, radiation therapy to the chest, radon gas, [[asbestos]], occupational exposure to chemical carcinogens, and previous lung disease.<ref>Lung cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/risks/?region=ab#Outdoor_air_pollution Accessed February 3, 2016</ref> | |||
==Screening== | ==Screening== | ||
Revision as of 16:06, 3 February 2016
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer overview On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer overview |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Non-small cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). Non-small cell lung cancer may be classified according to the WHO histological classification system into 3 main types: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Other less common subtypes, include: adenosquamous lung carcinoma, pulmonary sarcomatoid carcinoma, carcinoid tumors of lung, and carcinomas of the lung of salivary gland type.[1] NSCLC arises from the epithelial cells of the lung of the central bronchi to terminal alveoli. Genes involved in the pathogenesis of non-small cell lung cancer include EGFR, KRAS, HER2, BRAF, and ALK. The main cause of non-small cell lung cancer is DNA damage. Non-small cell lung cancer is the most common cancer among the adult population in the United States.[2][3] These tumors account for about 85% of all lung cancers. The incidence rate of non-small cell lung cancer is approximately 42.6 per 100 000 individuals in the United States. NSCLC tumors are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).
Historical Perspective
Non-small cell lung cancer was first described by Thomas Venner of London in 1620.[4]
Classification
Non-small cell lung cancer may be classified according to the WHO histological classification system into 3 main types: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Other less common subtypes, include: adenosquamous lung carcinoma, pulmonary sarcomatoid carcinoma, carcinoid tumors of lung, and carcinomas of the lung of salivary gland type.[1]
Pathophysiology
Non-small cell lung cancer arises from the epithelial cells of the lung of the central bronchi to terminal alveoli, which are normally involved in the protection of the airways. Non-small cell lung cancer is an invasive and rapidly growing cancer which may metastasize to different organs of the body. Genes involved in the pathogenesis of non-small cell lung cancer include EGFR, KRAS, HER2, BRAF, and ALK. On gross pathology, findings will depend on the histological type. On microscopic histopathological analysis non-small cell lung cancer demonstrate large cells with abundant cytoplasm and no stippled chromatin.
Causes
The primary cause of non-small cell lung cancer is DNA damage and genetic mutations in EGFR, KRAS, ALK, HER2, and BRAF genes.[3]
Differentiating Non Small Cell Carcinoma of the Lung from other Diseases
Non-small cell lung cancer must be differentiated from other diseases that cause chronic cough, weight loss, hemoptysis, and dyspnea among adults such as tuberculosis, fungal infections, and secondary metastases.
Epidemiology and Demographics
Non-small cell lung cancer is the most common cancer among the adult population in the United States.[2][3][5] These tumors account for about 85% of all lung cancers. The incidence rate of non-small cell lung cancer is approximately 42.6 per 100 000 individuals in the United States. The incidence of non-small cell lung cancer increases with age; the median age at diagnosis is between 5 to 7 years. Males are more commonly affected with non-small cell lung cancer than females. The male to female ratio is approximately 1.5 to 1.[2]
Risk Factors
Common risk factors in the development of non small cell lung are smoking, family history of lung cancer, high levels of air pollution, radiation therapy to the chest, radon gas, asbestos, occupational exposure to chemical carcinogens, and previous lung disease.[6]
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
References
- ↑ 1.0 1.1 Non-Small Cell Lung Cancer Treatment –for health professionals. National Cancer Institute – Physician Data Query PDQ. http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#link/_361_toc Accessed on February 3, 2016.
- ↑ 2.0 2.1 2.2 SEER Stat Fact Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.html Accessed on February 3 2016
- ↑ 3.0 3.1 3.2 Non-small cell lung cancer. https://en.wikipedia.org/wiki/Non-small-cell_lung_carcinoma Accessed on February 3 2016 </ref name="FACTS">American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society, 2016. Available online. Accessed February 3
- ↑ Witschi H (2001). "A short history of lung cancer". Toxicological Sciences : an Official Journal of the Society of Toxicology. 64 (1): 4–6. PMID 11606795. Retrieved 2011-12-09. Unknown parameter
|month=ignored (help) - ↑ American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society, 2016. Available online. Accessed February 3
- ↑ Lung cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/risks/?region=ab#Outdoor_air_pollution Accessed February 3, 2016